Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Hematology

Are T cell-based therapies like CAR-T effective for treating hematologic malignancies?

Yes, CAR-T cell therapy is highly effective for hematologic malignancies, with success in blood cancers like ALL, but faces challenges in solid tumors.

Gastroenterology

Does the aMAP risk score predict mortality for patients with Alcoholic Liver Disease?

The aMAP risk score is associated with increased mortality in patients with alcohol-related liver disease.

Oncology

How well does osimertinib work for lung cancer patients who have active brain metastasis?

Osimertinib is effective for EGFR-mutated NSCLC patients with active brain metastases, with real-world data showing median progression-free survival of 12.4 months and…

Oncology

Can a high neutrophil-to-lymphocyte ratio predict if a lung cancer patient will develop brain metastasis?

Yes, a high neutrophil-to-lymphocyte ratio (NLR) is linked to a higher risk of developing brain metastasis in lung cancer patients, according to a meta-analysis and other studies.

Oncology

What are the microenvironment mechanisms that drive lung cancer brain metastasis?

Lung cancer brain metastasis is driven by tumor cells co-opting brain developmental pathways, secreting exosomal CEMIP and LCN2, and recruiting astrocytes and macrophages to…

Oncology

Is stereotactic radiotherapy an effective treatment option for patients with brain metastasis?

Yes, stereotactic radiotherapy is an effective treatment for brain metastases, offering high local control rates and preserving cognitive function.

Oncology

Which method is best for placing fiducial markers before radiation for lung cancer?

Endobronchial access has the lowest inaccurate placement rate and low complication risk, making it a strong choice for fiducial marker insertion before lung cancer radiation.

Oncology

What are the risks of brain metastasis in patients diagnosed with lung cancer?

Brain metastases are common in lung cancer, especially small cell (15% at diagnosis) and non-small cell types, with elevated neutrophil-to-lymphocyte ratio as a risk factor…

Oncology

Can a high neutrophil-to-lymphocyte ratio predict if lung cancer will spread to the brain?

Yes, a high neutrophil-to-lymphocyte ratio (NLR) is an independent risk factor for brain metastasis in lung cancer, according to a meta-analysis of 14 studies.

Oncology

Does datopotamab deruxtecan improve survival for Hormone Receptor-Positive Breast Cancer?

Datopotamab deruxtecan did not improve overall survival compared to chemotherapy in metastatic HR-positive breast cancer, despite improving progression-free survival.

Oncology

Is trastuzumab deruxtecan better than chemotherapy for HR-positive breast cancer?

Yes, trastuzumab deruxtecan improves progression-free survival compared to chemotherapy in HR-positive, HER2-low breast cancer, but overall survival data are not yet mature.

Urology

Can dose intensification improve outcomes for intermediate- or high-risk prostate cancer?

Yes, early evidence suggests dose intensification to visible tumors may improve outcomes for intermediate- or high-risk prostate cancer, but ongoing trials will clarify safety…

Oncology

Can enzalutamide plus ADT improve survival for metastatic hormone-sensitive prostate cancer?

Yes, enzalutamide plus ADT significantly improves survival in metastatic hormone-sensitive prostate cancer, with a 34% reduction in risk of death and a 5-year survival rate of…

Oncology

Is there more research on macrophage polarization for prostate cancer since 2015?

Yes, research on macrophage polarization in prostate cancer has grown significantly since 2015, with studies exploring its role in tumor progression and therapy resistance.

Oncology

How do specific mutations affect treatment response in Colorectal Cancer?

Specific mutations like KRAS, BRAF, and MMR status strongly influence treatment response in colorectal cancer, guiding targeted therapy and immunotherapy decisions.

Oncology

What factors affect the quality of life for survivors of Colorectal Cancer?

Quality of life for colorectal cancer survivors is influenced by physical symptoms, psychological distress, social support, self-efficacy, and demographic factors like age and…

Oncology

What are the challenges of using artificial intelligence for Colorectal Cancer treatment?

AI in colorectal cancer treatment faces challenges including data quality and privacy issues, lack of generalizability, interpretability problems, and regulatory validation…

Gastroenterology

How does gut microbiota relate to the development of Colorectal Cancer?

Gut microbiota imbalances, including harmful bacteria like Fusobacterium nucleatum, can promote colorectal cancer through inflammation, DNA damage, and immune disruption, while…

Oncology

Can home exercise help reduce fatigue and anxiety in Colorectal Cancer patients?

Yes, home exercise may help reduce fatigue and anxiety in colorectal cancer patients, but the evidence is low certainty and more research is needed.

Oncology

What are the new treatments for triple-negative and HER2-positive Breast Cancer?

New treatments for triple-negative breast cancer include chemo-immunotherapy (pembrolizumab plus platinum-based chemo) and potential NY-ESO-1 targeted therapies; for…

Oncology

Can a plasma lipid panel help detect early stage Breast Cancer?

Yes, early research shows plasma lipid panels can help detect early-stage breast cancer, with machine learning models achieving high accuracy, but they are not yet standard…

Oncology

Can deep learning help doctors find Breast Cancer on tomosynthesis scans?

Yes, deep learning can help doctors find breast cancer on tomosynthesis scans, matching or improving radiologist accuracy in some cases.

Oncology

Is there any research on using AI for Breast Cancer pathology?

Yes, AI is being researched for breast cancer pathology, including digital pathology, deep learning for imaging, and machine learning for biomarker detection.

Anesthesiology & Pain Medicine

Does the PECS II block reduce morphine use after Breast Cancer surgery?

Yes, the PECS II block significantly reduces morphine use after breast cancer surgery, based on multiple randomized trials and a meta-analysis.

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.